Clinical Study

A Pilot Study on Bioactive Constituents and Analgesic Effects of MyrLiq®, a Commiphora myrrha Extract with a High Furanodiene Content

Table 2

Content of furanodienes in the two types of tablets containing either 200 mg or 400 mg of MyrLiq.

CompoundFuranodiene content in tablets containing 200 mg of MyrLiq (mg)Furanodiene content in tablets containing 400 mg of MyrLiq (mg)

Curzerene2.464.92
Furanoeudesma-1,3-diene3.777.54
Lindestrene1.252.50
Unknown furanodiene (MW = 216)0.060.12
Dihydrolinderalactone0.260.52
Acetoxy-furanodiene (MW = 274)0.120.24
Acetoxy-furanodiene (MW = 232)0.250.50
Total8.1716.34